Výsledky vyhledávání - Dimitri Breems

  • Zobrazuji výsledky 1 - 13 z 13
Upřesnit hledání
  1. 1
    Stroma-Contact Prevents Loss of Hematopoietic Stem Cell Quality During Ex Vivo Expansion of CD34+ Mobilized Peripheral Blood Stem Cells

    Stroma-Contact Prevents Loss of Hematopoietic Stem Cell Quality During Ex Vivo Expansion of CD34+ Mobilized Peripheral Blood Stem Cells Autor Dimitri Breems, Ellen A.W. Blokland, Karen E. Siebel, Angelique E. M. Mayen, Lilian J.A. Engels, Rob E. Ploemacher

    Vydáno 1998
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype

    Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype Autor Dimitri Breems, Wim L.J. van Putten, Georgine E. de Greef, Shama L. van Zelderen‐Bhola, Klasien B.J. Gerssen‐Schoorl, Clemens Mellink, Aggie Nieuwint, Martine Jotterand, Anne Hagemeijer, H. Berna Beverloo, Bob Löwenberg

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk Categories

    Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk Categories Autor Jan J. Cornelissen, Dimitri Breems, Wim L.J. van Putten, Aloïs Gratwohl, Jakob Passweg, Thomas Pabst, Johan Maertens, H. Berna Beverloo, Marinus van Marwijk Kooy, Pierre W. Wijermans, Bart J. Biemond, Edo Vellenga, Leo F. Verdonck, Gert J. Ossenkoppele, Bob Löwenberg

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival

    Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively aff... Autor Jesse M. Tettero, Lok Lam Ngai, Costa Bachas, Dimitri Breems, Thomas Fischer, Bjørn Tore Gjertsen, Patrycja Gradowska, Laimonas Griškevičius, Jeroen J.W.M. Janssen, Gunnar Juliusson, Johan Maertens, Markus G. Manz, Thomas Pabst, Jakob Passweg, Kimmo Porkka, Peter J.M. Valk, Bob Löwenberg, Gert J. Ossenkoppele, Jacqueline Cloos

    Vydáno 2023
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study

    Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study Autor Bob Löwenberg, Joachim Beck, Carlos Graux, Wim van Putten, Harry C. Schouten, Leo F. Verdonck, Augustin Ferrant, Pieter Sonneveld, Mojca Jongen‐Lavrencic, Marie von Lilienfeld‐Toal, Bart J. Biemond, Edo Vellenga, Dimitri Breems, Hilde de Muijnck, Ron Schaafsma, Gregor Verhoef, Hartmut Döhner, Aloïs Gratwohl, Thomas Pabst, Gert J. Ossenkoppele, Johan Maertens

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients

    Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients Autor Gerwin Huls, Dana Chiţu, Violaine Havelange, Mojca Jongen‐Lavrencic, Arjan A. van de Loosdrecht, Bart J. Biemond, Harm Sinnige, Beata Hodossy, Carlos Graux, Rien van Marwijk Kooy, Okke de Weerdt, Dimitri Breems, Saskia K. Klein, Jürgen Kuball, Dries Deeren, Wim Terpstra, Marie‐Christiane Vekemans, Gert J. Ossenkoppele, Edo Vellenga, Bob Löwenberg

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Molecular characterization of mutant <i>TP53</i> acute myeloid leukemia and high-risk myelodysplastic syndrome

    Molecular characterization of mutant <i>TP53</i> acute myeloid leukemia and high-risk myelodysplastic syndrome Autor Tim Grob, Adil S. A. Al Hinai, Mathijs A. Sanders, François G. Kavelaars, Melissa Rijken, Patrycja Gradowska, Bart J. Biemond, Dimitri Breems, Johan Maertens, Marinus van Marwijk Kooy, Thomas Pabst, Okke de Weerdt, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Gerwin Huls, Jan J. Cornelissen, H. Berna Beverloo, Bob Löwenberg, Mojca Jongen‐Lavrencic, Peter J.M. Valk

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents

    CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents Autor Tom Reuvekamp, Lok Lam Ngai, Daphne den Hartog, Jannemieke Carbaat‐Ham, Mona M.H.E Fayed, Willemijn J. Scholten, Tim R. Mocking, Dana Chiţu, Thomas Pabst, Saskia K. Klein, Georg Stüssi, Laimonas Griškevičius, Dimitri Breems, Daniëlle van Lammeren‐Venema, Rinske Boersma, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Costa Bachas, Gerwin Huls, David C. de Leeuw, Jacqueline Cloos

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK)

    Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON)... Autor Gert J. Ossenkoppele, Georg Stüssi, Johan Maertens, Kees van Montfort, Bart J. Biemond, Dimitri Breems, A. Ferrant, Carlos Graux, Georgine E. de Greef, Constantijn J.M. Halkes, Mels Hoogendoorn, Rene Hollestein, Mojca Jongen‐Lavrencic, Mark Levin, Arjan A. van de Loosdrecht, Marinus van Marwijk Kooij, Yvette van Norden, Thomas Pabst, Harry C. Schouten, Edo Vellenga, Gregor Verhoef, Okke de Weerdt, P. Wijermans, Jakob Passweg, Bob Löwenberg

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years

    Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years Autor Jan J. Cornelissen, Jurjen Versluis, Jakob Passweg, Wim L.J. van Putten, Markus G. Manz, Johan Maertens, H. Berna Beverloo, Peter J.M. Valk, Marinus van Marwijk Kooy, P. Wijermans, Martyn Ronald Schaafsma, Bart J. Biemond, MC Vekemans, Dimitri Breems, Leo F. Verdonck, Martin F. Fey, Mojca Jongen‐Lavrencic, Jeroen J.W.M. Janssen, Gerwin Huls, Jürgen Kuball, Thomas Pabst, Carlos Graux, Harry C. Schouten, Aloïs Gratwohl, Edo Vellenga, G.J. Ossenkoppele, Bob Löwenberg

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML

    Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML Autor Bob Löwenberg, Thomas Pabst, Johan Maertens, Yvette van Norden, Bart J. Biemond, Harry C. Schouten, Olivier Spertini, Edo Vellenga, Carlos Graux, Violaine Havelange, Georgine E. de Greef, Okke de Weerdt, Marie-Cecile J. C. Legdeur, Juergen Kuball, Marinus van Marwijk Kooy, Bjørn Tore Gjertsen, Mojca Jongen‐Lavrencic, Arjan A. van de Loosdrecht, Daniëlle van Lammeren‐Venema, Beata Hodossy, Dimitri Breems, Yves Chalandon, Jakob Passweg, Peter J.M. Valk, Markus G. Manz, Gert J. Ossenkoppele

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

    Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia Autor Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Lionel Karlin, Tadeusz Robak, Douglas E. Gladstone, Philipp le Coutre, Sascha Dietrich, Mirjana Gotić, Loree Larratt, Fritz Offner, Gary J. Schiller, Ronan Swords, Larry Bacon, Monica Bocchia, Krimo Bouabdallah, Dimitri Breems, Agostino Cortelezzi, Shira Dinner, Michael Doubek, Bjørn Tore Gjertsen, Marco Gobbi, Andrzej Hellmann, Stéphane Leprêtre, Frédéric Maloisel, Farhad Ravandi, Philippe Rousselot, Mathias Rummel, Tanya Siddiqi, Tamar Tadmor, Xavier Troussard, Cecilia Arana Yi, Giuseppe Saglio, Gail J. Roboz, Kemal Balic, Nathan Standifer, Peng He, Shannon Marshall, Wyndham H. Wilson, Ira Pastan, Nai-Shun Yao, Francis J. Giles

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

    Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial Autor Bob Löwenberg, Thomas Pabst, Johan Maertens, Patrycja Gradowska, Bart J. Biemond, Olivier Spertini, Edo Vellenga, Laimonas Griškevičius, Lidwine W. Tick, Mojca Jongen‐Lavrencic, Marinus van Marwijk Kooy, Marie-Christiane Vekemans, Walter J. F. M. van der Velden, Berna Beverloo, Lucienne Michaux, Carlos Graux, Dries Deeren, Okke de Weerdt, Joost W. J. van Esser, Mario Bargetzi, Saskia K. Klein, Alain Gadisseur, Peter E. Westerweel, Hendrik Veelken, Michael Gregor, Tobias Silzle, Daniëlle van Lammeren-Venema, Ine Moors, Dimitri Breems, Mels Hoogendoorn, Marie-Cecile J. C. Legdeur, Thomas Fischer, Juergen Kuball, Jan J. Cornelissen, Kimmo Porkka, Gunnar Juliusson, Peter Meyer, Martin Höglund, Bjørn Tore Gjertsen, Jeroen J.W.M. Janssen, Gerwin Huls, Jakob Passweg, Jacqueline Cloos, Peter J.M. Valk, Catharina H. M. J. Van Elssen, Markus G. Manz, Yngvar Fløisand, Gert J. Ossenkoppele

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: